Patient-reported outcome measures (PROMs) used to assess sexual functioning in prostate cancer patients: a systematic review of psychometric properties
Patient-reported outcome measures (PROMs) zur Beurteilung der sexuellen Funktion bei Prostatakrebspatienten: systematische Übersicht zu psychometrischen Eigenschaften
The Journal of Sexual Medicine · 15.04.2025 · 22 (4) · 605-624
DOI: 10.1093/jsxmed/qdaf018 ↗Auf einen Blick
Die systematische Übersicht identifizierte 10 PROMs in 32 Studien zur sexuellen Funktion bei Prostatakrebspatienten. EPIC-26 und UCLA-PCI zeigten die besseren psychometrischen Eigenschaften, erfüllten aber nicht alle COSMIN-Standards.
Fragestellung
Welche PROMs zur Erfassung der sexuellen Funktion bei Prostatakrebspatienten sind geeignet und wie gut sind ihre psychometrischen Eigenschaften?
Methode
Systematische Übersicht; 6 elektronische Datenbanken bis 5. Mai 2024; eingeschlossen waren Entwicklungs- und Validierungsstudien sowie generische Instrumente bei Prostatakrebspatienten; Bewertung mit COSMIN.
Ergebnisse
10 PROMs aus 32 Studien. Der Expanded Prostate Cancer Index Composite (EPIC-26) war am häufigsten untersucht und in der Praxis am häufigsten verwendet. EPIC-26 (Spanisch, Italienisch, Chinesisch) und UCLA-PCI zeigten bessere psychometrische Eigenschaften.
Einschränkungen
Strenge Einschlusskriterien zu Studiendesign und -population; keine PROM erfüllte alle COSMIN-Standards.
Schlussfolgerung der Autor:innen
EPIC-26 hat starke psychometrische Eigenschaften, ist für Patient:innen mit erheblichen Gesundheitsproblemen aber möglicherweise noch zu lang. Die eingeschlossenen PROMs decken Partnerschaft und psychologische Folgen nicht ausreichend ab.
Kernaussagen
- 10 PROMs wurden in 32 Studien identifiziert
- EPIC-26 und UCLA-PCI zeigten die besseren psychometrischen Eigenschaften
- Keine PROM erfüllte alle COSMIN-Standards
Deutsche Zusammenfassung: KI-gestützt aus dem Original-Abstract erstellt; alle Zahlen wurden automatisch mit dem Original abgeglichen. Maßgeblich ist der Original-Abstract.
Kurz gefasst
Systematische Übersicht in der Zeitschrift The Journal of Sexual Medicine, online erschienen am 20.02.2025. Verfasst von Hammoda Abu-Odah und 5 weiteren Autor:innen. Beteiligte Einrichtung: School of Nursing, The Hong Kong Polytechnic University, Hung Hom, Hong Kong SAR, 999077, China. Hauptthemen laut MEDLINE: Patient Reported Outcome Measures, Prostatic Neoplasms, Sexual Dysfunction, Physiological. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 76 Literaturangaben. Gefördert von: JC STEM Lab of Digital Oncology Care Enhancement, Hong Kong Jockey Club Charities Trust.
Themen: Onkologische Pflege
Abstract (Originalsprache)
Background
Prostate cancer (PCa) significantly impacts patients’ sexual functioning and quality of life. Patient-reported outcome measures (PROMs) are essential for accurately assessing these issues, yet a comprehensive evaluation of their psychometric properties in PCa patients is lacking.
Aims
This systematic review aimed to provide a comprehensive evaluation of all generic and specific PROMs used to assess sexual functioning in PCa patients and make recommendations the application of PROMs in this patient group.
Methods
Six electronic databases were searched from up to May 5, 2024. Studies reporting the development and/or validation of PROMs for PCa patients or generic instruments administered to this population were included. The COSMIN risk of bias checklist was adopted to assess the methodological quality and psychometric properties of included PROMs. Psychometric properties of the PROM in each included study were rated against the criteria for good measurement properties based on the COSMIN guideline. Outcomes The main outcome was to identify the appropriate PROM that can be adopted and used for assessing sexual functioning in PCa patients in clinical setting.
Results
A total of 10 PROMs were identified across 32 studies, primarily focusing on localized PCa patients after radical prostatectomy. The Expanded Prostate Cancer Index Composite (EPIC-26) was the most frequently evaluated and widely used PROM in clinical practice. EPIC-26 (Spanish, Italian, Chinese versions) and UCLA Prostate Cancer Index (UCLA-PCI) demonstrated better psychometric properties compared to other scales. However, no PROM met all COSMIN standards. Clinical Implications In a clinical setting, it is crucial to utilize well-validated PROMs with good psychometric properties to effectively identify patients with PCa experiencing sexual difficulties who may require additional support. Strengths and Limitations We applied strict inclusion criteria related to study design and study population, ensuring the assumption of transitivity and the consistency of the analysis.
Conclusion
Although EPIC-26 is a shortened version with strong psychometric properties, it may still be too lengthy for patients with significant health issues. Furthermore, the included PROMs do not address issues related to partner relationships, or the psychological impact of sexual dysfunction in sufficient detail. Future research should aim to develop and validate new PROMs that fill these gaps. These tools should be both psychometrically robust and practical for routine use, enabling real-time monitoring and improved care delivery.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- School of Nursing, The Hong Kong Polytechnic University, Hung Hom, Hong Kong SAR, 999077, China.
- SH Ho Urology Center, Department of Surgery, The Chinese University of Hong Kong, Hong Kong SAR, 999077, China.
- Department of Nursing, The First Affiliated Hospital of Zhejiang University School of Medicine, Hangzhou, China.
- Department of Nursing, School of Medicine, Zhejiang University, Hangzhou 310058, China.
Förderung
- JC STEM Lab of Digital Oncology Care Enhancement
- Hong Kong Jockey Club Charities Trust
Zitieren
APA
Abu-Odah, H., Ho, K. Y., Ng, C. F., Wu, S., Lam, K. K., & Yorke, J. (2025). Patient-reported outcome measures (PROMs) used to assess sexual functioning in prostate cancer patients: a systematic review of psychometric properties. The Journal of Sexual Medicine, 22(4), 605-624. https://doi.org/10.1093/jsxmed/qdaf018
Vancouver
Abu-Odah H, Ho KY, Ng CF, Wu S, Lam KK, Yorke J. Patient-reported outcome measures (PROMs) used to assess sexual functioning in prostate cancer patients: a systematic review of psychometric properties. The Journal of Sexual Medicine. 2025;22(4):605-624. doi:10.1093/jsxmed/qdaf018
BibTeX
@article{AbuOdah2025,
author = {Abu-Odah, Hammoda and Ho, Ka-Yan and Ng, Chi-Fai and Wu, Siyuan and Lam, Katherine-Ka-Wai and Yorke, Janelle},
title = {Patient-reported outcome measures (PROMs) used to assess sexual functioning in prostate cancer patients: a systematic review of psychometric properties},
journal = {The Journal of Sexual Medicine},
year = {2025},
volume = {22},
number = {4},
pages = {605--624},
doi = {10.1093/jsxmed/qdaf018}
}
EUVIMED